Indeed, miR-200c, through the downregulation of HMOX1, a target gene of NRF2, sensitizes ccRCC to chemotherapeutic agents [92], suggesting that miRNAs regulation of the NRF2-ARE signature can impact on different features of RCC. Here, NFE2L2 is linked to nonpapillary renal cell carcinoma.